Streetbeat News

Price Targets

APGE

BTIG analyst Julian Harrison has initiated coverage on Apogee Therapeutics (NASDAQ:APGE) with a Buy rating and set a price target of $43.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:44 pm

FUSN

RBC Capital analyst Gregory Renza has initiated coverage on Fusion Pharmaceuticals (NASDAQ:FUSN) with an Outperform rating and set a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:42 pm

DESP

B. Riley Securities analyst Naved Khan has reaffirmed a Buy rating on Despegar.com (NYSE:DESP) and increased the price target from $12 to $15, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:41 pm

NVEI

Barclays analyst John Coffey has initiated coverage on payment technology company Nuvei (NASDAQ:NVEI) with an Overweight rating and set a price target of $34. This new coverage could influence investor sentiment and potentially affect the stock's performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:36 pm

CKPT

B. Riley Securities analyst Mayank Mamtani has maintained a Buy rating on Checkpoint Therapeutics (NASDAQ:CKPT) but has reduced the price target from $8 to $4. The report was released on December 19, 2023.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:34 pm

CKPT

B. Riley Securities analyst Mayank Mamtani has maintained a Buy rating on Checkpoint Therapeutics (NASDAQ:CKPT) but has reduced the price target from $8 to $4.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:34 pm

FDX

FedEx Corp (NYSE:FDX) stock fell after reporting Q2 revenue and EPS below estimates, with revenue at $22.2 billion against estimates of $22.39 billion, and EPS at $3.99 versus $4.19 expected. Despite lower revenue, operating income increased, attributed to the company's DRIVE program. FedEx expects a low-single-digit percentage decline in full-year 2024 revenue and forecasts earnings of $17 to $18.50 per share, below the $18.25 estimate. Analysts at JPMorgan and Barclays lowered their price targets for FedEx following the results.

Portfolio Pulse from Adam Eckert

December 20, 2023 | 1:34 pm

SHAK

HSBC analyst Meredith Jensen has initiated coverage on Shake Shack (NYSE:SHAK) with a Hold rating and set a price target of $74 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:32 pm

SBUX

HSBC analyst Meredith Jensen has initiated coverage on Starbucks (NASDAQ:SBUX) with a Hold rating and set a price target of $107 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:30 pm

BYRN

B. Riley Securities analyst Jeff Van Sinderen has maintained a Buy rating on Byrna Technologies (NASDAQ:BYRN) and increased the price target from $7 to $8.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:29 pm